ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT00070018

Public ClinicalTrials.gov record NCT00070018. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of CHOP Plus Involved Field Radiotherapy Followed by Yttrium-90 Ibritumomab Tiuxetan for Stages I, IE, and Non-Bulky Stages II and IIE, CD20 Positive, High-Risk Localized, Aggressive Histologies of Non-Hodgkin Lymphoma, Phase II

Study identification

NCT ID
NCT00070018
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
46 participants

Conditions and interventions

Conditions

Interventions

  • Cyclophosphamide Drug
  • Indium-111 ibritumomab tiuxetan Biological
  • Yttrium-90 ibritumomab tiuxetan Biological
  • doxorubicin hydrochloride Drug
  • prednisone Drug
  • radiation therapy Radiation
  • rituximab Biological
  • vincristine sulfate Drug

Drug · Biological · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2004
Primary completion
Oct 31, 2010
Completion
Jan 7, 2015
Last update posted
Jan 10, 2022

2004 – 2015

United States locations

U.S. sites
48
U.S. states
10
U.S. cities
36
Facility City State ZIP Site status
Alaska Regional Hospital Cancer Center Anchorage Alaska 99508
Providence Cancer Center Anchorage Alaska 99508
Providence Saint Joseph Medical Center - Burbank Burbank California 91505
Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise Idaho 83712
Decatur Memorial Hospital Cancer Care Institute Decatur Illinois 62526
Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood Illinois 60153
Edward Hospital Cancer Center Naperville Illinois 60540
Regional Cancer Center at Memorial Medical Center Springfield Illinois 62781-0001
Cancer Center of Kansas, PA - Chanute Chanute Kansas 66720
Cancer Center of Kansas, PA - Dodge City Dodge City Kansas 67801
Cancer Center of Kansas, PA - El Dorado El Dorado Kansas 67042
Cancer Center of Kansas-Independence Independence Kansas 67301
Cancer Center of Kansas, PA - Kingman Kingman Kansas 67068
Southwest Medical Center Liberal Kansas 67901
Cancer Center of Kansas, PA - Newton Newton Kansas 67114
Cancer Center of Kansas, PA - Parsons Parsons Kansas 67357
Cancer Center of Kansas, PA - Pratt Pratt Kansas 67124
Cancer Center of Kansas, PA - Salina Salina Kansas 67042
Cotton-O'Neil Cancer Center Topeka Kansas 66606
Cancer Center of Kansas, PA - Wellington Wellington Kansas 67152
Associates in Womens Health, PA - North Review Wichita Kansas 67208
Cancer Center of Kansas, PA - Medical Arts Tower Wichita Kansas 67208
Cancer Center of Kansas, PA - Wichita Wichita Kansas 67214
CCOP - Wichita Wichita Kansas 67214
Via Christi Cancer Center at Via Christi Regional Medical Center Wichita Kansas 67214
Wesley Medical Center Wichita Kansas 67214
Cancer Center of Kansas, PA - Winfield Winfield Kansas 67156
Battle Creek Health System Cancer Care Center Battle Creek Michigan 49017
Mecosta County Medical Center Big Rapids Michigan 49307
Butterworth Hospital at Spectrum Health Grand Rapids Michigan 49503
CCOP - Grand Rapids Grand Rapids Michigan 49503
Lacks Cancer Center at Saint Mary's Health Care Grand Rapids Michigan 49503
Hackley Hospital Muskegon Michigan 49442
Providence Cancer Institute at Providence Hospital - Southfield Campus Southfield Michigan 48075
Munson Medical Center Traverse City Michigan 49684
Metro Health Hospital Wyoming Michigan 49519
James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester New York 14642
McDowell Cancer Center at Akron General Medical Center Akron Ohio 44307
Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio 45267
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
Community Oncology Group at Cleveland Clinic Cancer Center Independence Ohio 44131
Cleveland Clinic - Wooster Wooster Ohio 44691
CCOP - Greenville Greenville South Carolina 29615
Minor and James Medical, PLLC Seattle Washington 98104
Group Health Central Hospital Seattle Washington 98112
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle Washington 98122-4307
Polyclinic First Hill Seattle Washington 98122
University Cancer Center at University of Washington Medical Center Seattle Washington 98195-6043

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00070018, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 10, 2022 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00070018 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →